C Pierfitte
Impact in
- Toxicology top 5%
- Pharmacovigilance and Adverse Drug Reactions
- Orthopedics and Sports Medicine top 10%
- Tendon Structure and Treatment
- Sports injuries and prevention
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 4
- Pharmaceutical industry and healthcare 1
-
- Pharmacovigilance and Adverse Drug Reactions 2
- Co-authors
- R J Royer (2 shared papers)P. Netter (2 shared papers)Nicholas Moore (3 shared papers)Rajaa Lagnaoui (2 shared papers)Bernard Bégaud (1 shared paper)Bernard Bégaud (2 shared papers)René Royer (1 shared paper)Fabienne Péhourcq (1 shared paper)
- Journals
- British Journal of Clinical Pharmacology (2 papers)Clinical Pharmacology & Therapeutics (1 paper)Fundamental and Clinical Pharmacology (1 paper)BMJ (1 paper)PubMed (4 papers)
- Partner nations
- France
In The Last Decade
C Pierfitte
9 papers receiving 368 citations
Peers
Comparison fields: 5 of 65
- Toxicology 52
- Orthopedics and Sports Medicine 60
- Pharmacology 115
- Geriatrics and Gerontology 15
- Physical Therapy, Sports Therapy and Rehabilitation 16
Countries citing papers authored by C Pierfitte
This map shows the geographic impact of C Pierfitte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Pierfitte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Pierfitte more than expected).
Fields of papers citing papers by C Pierfitte
This network shows the impact of papers produced by C Pierfitte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Pierfitte. The network helps show where C Pierfitte may publish in the future.
Co-authors
The 19 scholars most cited alongside C Pierfitte, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 95 | |
| 2 | Features of tendon disorders with fluoroquinolones. | 1994 | 86 |
| 3 | 1999 | 73 | |
| 4 | Tendon disorders with fluoroquinolones. | 1997 | 63 |
| 5 | 2001 | 28 | |
| 6 | 2000 | 26 | |
| 7 | 1995 | 11 | |
| 8 | [Opinion survey of European pharmacovigilance: opinion of French practitioners]. | 1995 | 3 |
| 9 | [Pseudomembranous colitis associated with josamycin]. | 1995 | 2 |
About C Pierfitte
C Pierfitte is a scholar working on Pharmacology, Toxicology, Public Health, Environmental and Occupational Health, Experimental and Cognitive Psychology and Infectious Diseases, having authored 9 papers that have together received 387 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Streptococcal Infections and Treatments (2 papers), Sleep and related disorders (2 papers), Pharmacovigilance and Adverse Drug Reactions (2 papers), Phenothiazines and Benzothiazines Synthesis and Activities (1 paper), Tuberculosis Research and Epidemiology (1 paper), Pharmaceutical industry and healthcare (1 paper) and Pharmaceutical Economics and Policy (1 paper). The work is most often cited by research in Toxicology (52 citations), Orthopedics and Sports Medicine (60 citations), Pharmacology (115 citations), Geriatrics and Gerontology (15 citations) and Physical Therapy, Sports Therapy and Rehabilitation (16 citations). C Pierfitte has collaborated with scholars based in France. Frequent co-authors include R J Royer, P. Netter, Nicholas Moore, Rajaa Lagnaoui, Bernard Bégaud, Bernard Bégaud, René Royer, Fabienne Péhourcq, Pierre Gillet and D. Hestin. Their work appears in journals such as British Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics, Fundamental and Clinical Pharmacology, BMJ and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.